Suppr超能文献

术后C反应蛋白与白蛋白比值可预测接受根治性膀胱切除术的膀胱癌患者的不良预后。

Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy.

作者信息

Kuroda Kenji, Tasaki Shinsuke, Horiguchi Akio, Ito Keiichi

机构信息

Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.

出版信息

Mol Clin Oncol. 2021 Mar;14(3):54. doi: 10.3892/mco.2021.2216. Epub 2021 Jan 21.

Abstract

The purpose of the present study was to investigate the prognostic value of the postoperative C-reactive protein/albumin ratio (CAR) in patients with bladder cancer undergoing radial cystectomy. The present study retrospectively reviewed 102 patients who underwent radical cystectomy and were followed for ≥6 months postoperatively at our institution, and evaluated clinicopathological factors and laboratory parameters for cancer-specific survival (CSS) and extraurothelial recurrence-free survival (ERFS). Multivariate analysis using the Cox proportional hazards model revealed that only postoperative CAR ≥0.27 [hazard ratio (HR), 3.368; 95% confidence interval (CI), 1.674-6.731; P<0.001] was an independent factor for poor CSS rate. Higher postoperative CAR was also the only significant factor for shortened ERFS time (HR, 2.401; 95% CI, 1.196-4.684; P=0.015). No significant association was identified between postoperative CAR ≥0.27 and any pathological factors or postoperative laboratory markers besides postoperative neutrophil-to-lymphocyte ratio. Furthermore, postoperative CAR (≥0.27) was an independent factor for poor CSS and ERFS rates in 48 patients with advanced pT stage (≥pT3) in the multivariate analysis (P=0.026 and P=0.036, respectively). A higher postoperative CAR value can provide additional information about the possibility of poor CSS and ERFS rates in patients with bladder cancer undergoing radical cystectomy.

摘要

本研究的目的是探讨术后C反应蛋白/白蛋白比值(CAR)对接受根治性膀胱切除术的膀胱癌患者的预后价值。本研究回顾性分析了102例行根治性膀胱切除术且在我院术后随访≥6个月的患者,并评估了临床病理因素及实验室参数对癌症特异性生存(CSS)和非尿路上皮无复发生存(ERFS)的影响。使用Cox比例风险模型进行多因素分析显示,仅术后CAR≥0.27[风险比(HR),3.368;95%置信区间(CI),1.674 - 6.731;P<0.001]是CSS率低的独立因素。术后CAR升高也是ERFS时间缩短的唯一显著因素(HR,2.401;95%CI,1.196 - 4.684;P = 0.015)。除术后中性粒细胞与淋巴细胞比值外,未发现术后CAR≥0.27与任何病理因素或术后实验室指标之间存在显著关联。此外,在多因素分析中,术后CAR(≥0.27)是48例pT分期晚期(≥pT3)患者CSS和ERFS率低的独立因素(分别为P = 0.026和P = 0.036)。较高的术后CAR值可为接受根治性膀胱切除术的膀胱癌患者CSS和ERFS率低的可能性提供额外信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd33/7849063/17d088457d27/mco-14-03-02216-g00.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验